Prostate cancer progression: Sodium salicylate, the active metabolite of aspirin inhibits nuclear factor-kappa B (NFkB) pathway

Olaniyi Ogundiya, Helen Whiteland, U. K. Shah, O. Bodger, H. Haboubi, H. Kynaston, S. Doak

Allbwn ymchwil: Cyfraniad at gynhadledd › Crynodeb › adolygiad gan gymheiriaid

Ôl bys

Gweld gwybodaeth am bynciau ymchwil 'Prostate cancer progression: Sodium salicylate, the active metabolite of aspirin inhibits nuclear factor-kappa B (NFkB) pathway'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science